Co-Authors
This is a "connection" page, showing publications co-authored by Yiska Weisblum and Theodora Hatziioannou.
Connection Strength
0.920
-
Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 Patients. J Clin Microbiol. 2020 11 18; 58(12).
Score: 0.228
-
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. Elife. 2020 10 28; 9.
Score: 0.228
-
Absence of Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Activity in Prepandemic Sera From Individuals With Recent Seasonal Coronavirus Infection. Clin Infect Dis. 2021 09 07; 73(5):e1208-e1211.
Score: 0.060
-
Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations. Immunity. 2021 08 10; 54(8):1853-1868.e7.
Score: 0.060
-
Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies. Nat Commun. 2021 07 07; 12(1):4196.
Score: 0.060
-
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants. Nature. 2021 04; 592(7855):616-622.
Score: 0.058
-
Evolution of antibody immunity to SARS-CoV-2. Nature. 2021 03; 591(7851):639-644.
Score: 0.058
-
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses. J Exp Med. 2020 11 02; 217(11).
Score: 0.057
-
Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies. Cell. 2020 08 20; 182(4):828-842.e16.
Score: 0.056
-
Convergent antibody responses to SARS-CoV-2 in convalescent individuals. Nature. 2020 08; 584(7821):437-442.
Score: 0.055